CompletedNCT02055183

BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin

Studying Botulism

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emergent BioSolutions
Principal Investigator
Jason S Richardson, Ph.D.
Emergent BioSolutions
Intervention
BAT(drug)
Enrollment
162 enrolled
Eligibility
All sexes
Timeline
2014 – 2017

Collaborators

Biomedical Advanced Research and Development Authority · Centers for Disease Control and Prevention

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02055183 on ClinicalTrials.gov

Other trials for Botulism

Additional recruiting or active studies for the same condition.

See all trials for Botulism →

← Back to all trials